(1988), at the Medical University of Bialystok, Poland demonstrated that intracerebroventricular injection of Ang IV (Val-Tyr-Ile-His-Pro-Phe), 1 in rat (1 nmol dose) improved memory and learning (Figure 1)
Adequate choline intake increases to 550 mg/day in lactating women
Supplement Companies Are Not Allowed to Sell BPC-157 BPC157 is not recognized as a dietary ingredient and is not allowed in supplements under the Dietary Supplement Health and Education Act (DSHEA)
The pricing is straightforward: 2.99% of collections for medical billing, $99 per payer for enrollment and credentialing
Neonatal jaundice is a distinct, highly prevalent entity: physiologic hyperbilirubinemia affects up to 60% of term neonates in the first week of life due to fetal hemoglobin breakdown, immature hepatic conjugation capacity, and enterohepatic recirculation (AAP Clinical Practice Guideline on Hyperbilirubinemia)
Sensory Symptoms Numbness, tingling, or pins and needles (paresthesia) typically distal/stocking-glove in polyneuropathy Burning pain, allodynia, hyperalgesia common in small-fiber predominant neuropathy and CIDP Loss of proprioception and vibration sense sensory ataxia, positive Romberg sign Loss of pain/temperature sensation (small fiber) risk of unnoticed wounds Motor Symptoms Distal muscle weakness (foot drop in peroneal neuropathy, wrist drop in radial neuropathy) Atrophy of intrinsic hand muscles (ulnar/median neuropathy) Hyporeflexia or areflexia (ankle jerks lost early in length-dependent polyneuropathy) Fasciculations in severe axonal loss Autonomic Symptoms Orthostatic hypotension, dizziness on standing Gastroparesis, constipation or diarrhea, nausea Neurogenic bladder (hesitancy, retention, incontinence) Anhidrosis or gustatory sweating Sexual dysfunction
